| Net Cash Provided by (Used in) Operating Activities |
$404,621 |
USD |
-580% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,370,383 |
USD |
17821% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
45,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
11,653,705 |
shares |
629% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$684,295 |
USD |
681% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$56 |
USD |
-72% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$12,362,000 |
USD |
0.59% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$9,042,902 |
USD |
2.9% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
39,810 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
900,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$40,618,459 |
USD |
15% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
39,810 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$164,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |